Your Heart, Your Mouth, Your Bleeding — Three Things Worth Knowing
Quick Summary
A new study on estrogen types and heart failure markers shows the relationship looks different in women than in men — and the details matter. Research also links longer time since menopause to more oral health problems. And a study on postmenopausal bleeding makes the case for a specific two-step diagnostic approach.
Your Heart, Your Mouth, Your Bleeding — Three Things Worth Knowing
Key Takeaways
- ✦In women with heart failure, higher levels of estrone relative to estradiol were associated with worse heart strain markers — a pattern that didn't show up the same way in men.
- ✦Estrone (the weaker estrogen that becomes dominant after menopause) and estradiol (the stronger form that drops sharply at menopause) behave differently in the body, and treating them as interchangeable may be a mistake.
- ✦The cross-sectional study on oral health found that women who had been in menopause longer were more likely to show gum disease, dry mouth, and bone loss in the jaw — though this type of study can't prove cause and effect.
- ✦Postmenopausal bleeding is not normal and should always be evaluated — the study found that combining transvaginal 3D ultrasound with hysteroscopy caught more problems than either test alone.
- ✦Hysteroscopy (a small camera inside the uterus) can both diagnose and treat certain causes of postmenopausal bleeding in the same procedure.
Sources & References
Episode Script
Thanks Toni. We've got a good one today — three studies, all published this week, covering some ground that doesn't get nearly enough airtime.
The first one is about your heart. Specifically, about estrogen and heart failure — but with a twist I haven't seen framed quite this way before.
Most of the conversation about estrogen and heart health focuses on how much estrogen you have. This study, published November 19th and led by Nakamura and colleagues, asks a different question: does the ratio between two types of estrogen matter for heart health? And the answer, at least in this group of older adults with heart failure, appears to be yes — but only in women.
So let me back up and explain the two estrogens in question, because this matters.
Estradiol is the potent form of estrogen. It's the one that's high during your reproductive years and drops sharply at menopause. Estrone is the weaker form. It's always been in the background, but after menopause, it becomes the dominant estrogen your body produces — mostly made in fat tissue. The two are related; your body converts estradiol into estrone as estradiol falls.
For a long time, researchers treated these as basically the same thing — just "estrogen." This study pushes back on that.
What the researchers found was that in women with heart failure, a higher ratio of estrone to estradiol — meaning more of the weaker form relative to the stronger one — was linked to higher levels of something called BNP, or B-type natriuretic peptide. BNP is a marker your heart releases when it's under strain. High BNP is not good news. It signals the heart is working too hard.
In men with heart failure, that same estrone-to-estradiol ratio didn't show the same association. The pattern was specific to women.
Now, I want to be clear about what this study is and isn't. It's observational, which means it shows an association, not a cause. We can't say from this data that having more estrone causes worse heart function. It could be that women who are sicker have different estrogen metabolism for other reasons. The study is also limited to people who already have heart failure, so we can't extrapolate this to healthy women in menopause and say "your estrone balance predicts your heart risk." That's not what the data shows.
What it does suggest is that lumping estrone and estradiol together as a single category called "estrogen" might be making us miss something. If the type of estrogen matters — not just the total amount — then how we measure and interpret estrogen levels in postmenopausal women may need to get more specific. That's a meaningful shift in thinking, even if this is early-stage research.
The kind of evidence your doctor would look at on a tool like OpenEvidence doesn't yet support clinical changes based on this one study. But it's the kind of finding that pushes researchers toward the next question — which is what good science is supposed to do.
Gum disease isn't something most people associate with menopause. But there's a growing body of research connecting the two, and a cross-sectional study published by Santhiya and colleagues adds another data point.
This one looked at the relationship between how long a woman had been in menopause and her oral health. The researchers found that women who had been postmenopausal for longer showed higher rates of gum disease, dry mouth, and bone loss in the jaw compared to women who were more recently menopausal.
The proposed mechanism here isn't complicated. Estrogen has anti-inflammatory effects throughout the body, and your gums and the bone that holds your teeth in place are not exempt from that. When estrogen drops, inflammation can increase. Saliva production may also decrease, which matters because saliva is actually a frontline defense for your mouth — it buffers acid, helps clear bacteria, and keeps tissue healthy. Less saliva means a less protected mouth over time.
The study was cross-sectional, which means they looked at a group of women at one point in time — not followed them over years. So it can tell us that longer menopause duration and worse oral health tend to appear together, but it can't prove that one caused the other. Women who've been postmenopausal longer are also just older, and age itself is a factor in oral health. Separating those effects isn't something a cross-sectional design can fully do.
That caveat aside, this fits a pattern that's been building in the literature. And it has a pretty direct practical implication: if you're postmenopausal and you haven't been to a dentist recently, that's not a neutral choice the way it might have been in your thirties. The window where small gum problems become bigger structural problems can shorten after menopause. Regular dental care stops being optional maintenance and starts being something closer to preventive medicine.
The dry mouth piece is worth flagging separately, because it often gets dismissed as minor. It isn't. Persistent dry mouth increases your cavity risk, makes it harder to swallow and speak comfortably, and is one of the more quietly miserable things women report in perimenopause and beyond. If that's something you're dealing with and you've mentioned it at a routine checkup and been handed a tube of special toothpaste — it's worth having a fuller conversation about what's driving it and what the actual options are.
Postmenopausal bleeding. If you've experienced it or you're in the age range where you might, pay attention here.
Any bleeding after menopause — meaning after 12 consecutive months without a period — is not normal and needs to be investigated. That's not alarmism; that's just the standard of care, and it exists for good reason. Most of the time the cause turns out to be benign: atrophy of the vaginal and uterine lining, a small polyp, something treatable. But postmenopausal bleeding can also be an early sign of uterine cancer, and uterine cancer caught early has very good outcomes. Caught late, it doesn't. So the evaluation matters.
A study from Sharma and colleagues looked at how to do that evaluation well. Specifically, they compared two tools: transvaginal 3D power Doppler ultrasound — an imaging technique that can look at blood flow patterns in the uterus in three dimensions — and hysteroscopy, which is a small camera passed through the cervix to look directly inside the uterus.
What they found was that neither test alone caught everything. The ultrasound was good at flagging structural changes and abnormal blood flow. The hysteroscopy was better at identifying things like polyps and certain types of tissue changes on the uterine lining. When both were used together, the diagnostic accuracy was higher than either alone.
There's also a practical upside to hysteroscopy that's worth knowing: it's not just diagnostic. For certain causes of postmenopausal bleeding — polyps, for example — a hysteroscopy can remove the problem in the same procedure. You're not waiting for a second appointment.
The study was relatively small and conducted at a single center, which limits how broadly we can generalize the findings. But the conclusion — that combining imaging with direct visualization gives you more information than one alone — is clinically sensible and aligns with what more comprehensive menopause and gynecological care guidelines already tend to recommend.
My take on this one is straightforward: if you go to your doctor with postmenopausal bleeding and walk out with only reassurance and no workup, that's not acceptable. It doesn't mean something is wrong. It means something needs to be ruled out. The evaluation exists to give you the answer. Push for it.
Sources curated automatically by the Hot Flasher pipeline.
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.